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Direct mass spectrometric analysis of complex biological samples is becoming an increasingly
useful technique in the field of proteomics. Matrix-assisted laser desorption/ionization mass
spectroscopy (MALDI-MS) is a rapid and sensitive analytical tool well suited for obtaining
molecular weights of peptides and proteins from complex samples. Here, a fast and simple
approach to cellular protein profiling is described in which mammalian cells are lysed directly
in the MALDI matrix 2,5-dihydroxybenzoic acid (DHB) and mass analyzed using MALDI-time
of flight (TOF). Using the unique MALDI mass spectral “fingerprint” generated in these
analyses, it is possible to differentiate among several different mammalian cell lines. A number
of techniques, including MALDI-post source decay (PSD), MALDI tandem time-of-flight
(TOF-TOF), MALDI-Fourier transform ion cyclotron resonance (FTICR), and nanoflow liquid
chromatography followed by electrospray ionization and tandem mass spectrometry (LC-ESI-
MS/MS) were employed to attempt to identify the proteins represented in the MALDI spectra.
Performing a tryptic digestion of the supernatant of the cells lysed in DHB with subsequent
LC-ESI-MS/MS analysis was by far the most successful method to identify proteins. (J Am
Soc Mass Spectrom 2006, 17, 490–499) © 2006 American Society for Mass SpectrometryThere is great interest in characterizing the pro-teins present in cells. Among the many vitalfunctions they perform, proteins catalyze a vari-
ety of chemical reactions, support a range of skeletal
structures, control membrane permeability, modulate
the concentration of metabolites, and control gene ex-
pression. Mass spectrometric analysis of both bacterial
and mammalian cells has been a rapidly developing
and important field over the last decade.
MALDI mass spectrometry [1, 2] has been applied to
both the analysis of whole bacterial cells [3– 6] and the
analysis of proteins extracted from bacterial cells [4, 7].
Both mild aqueous acids [3, 7] and acidic MALDI
matrices [3, 4, 7, 8] have been employed to extract
proteins from bacterial cells. MALDI-TOF analysis of
proteins extracted directly from bacterial cells without
prior sample clean-up has been reported [3, 4, 7].
However, to our knowledge, this is the first report of
mammalian cells analyzed directly after extraction into
a MALDI matrix.
Studies involving mass spectral analysis of mamma-
lian cells have been more extensive than those involving
bacterial cells. Analyses of mammalian cells using mass
spectrometry can be split into two categories—studies
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doi:10.1016/j.jasms.2005.12.007involving a large number of cells and studies involving
single cells. Working with a large number of cells, mass
spectrometry has been employed to quantify changes in
protein expression between two populations of cells
using stable isotope labels [9 –19], to generate diagnostic
patterns denoting a disease state [20 –24], and to iden-
tify proteins important in various cellular functions and
pathways (i.e., differentiation, transcription, translation,
ubiquitination, membrane proteins) [25– 40].
Various techniques have been employed to extract
information about the protein composition of cells
before MS analysis. Cell lysis is a major step in sample
preparation, and the choice of the lysis protocol is an
important factor in the success of the subsequent assay.
For mammalian cell lysis, PBS buffer [41] or lysis buffer
[42, 43] followed by mechanical disruption, such as
vortexing or ultrasonical disruption, are the most com-
mon techniques employed. Centrifugation is commonly
employed to remove insoluble cellular debris from the
protein-containing supernatant. A common disadvan-
tage of these protocols is the biased selection of certain
protein classes occurring during the course of the lysate
preparation. In addition, almost all of the techniques
currently used in proteomics combine a variety of
fractionation and separation steps before analysis by
MS. These protocols include purifications that yield a
specific group of compounds for analysis rather than
measurement of the cell in entirety. Typical separation
procedures include affinity separation methods [44–
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2-D chromatographic separations [53–56]. These meth-
ods have high-resolution and can provide a great quan-
tity of information. However, the limitation of these
methods is their laborious and time-consuming nature.
Many methods and technologies have been developed
and applied in single cell analysis. Generally, a single cell
has been isolated using micropipettes, optical traps, or
dielectrophoresis [57– 61]. After injection into a capillary
or into a microfluidic channel, the intact cell undergoes
lysis to release cellular components. Capillary electro-
phoresis has commonly been used as a separation tech-
nique before MS analysis [62– 64]. However, the sensitiv-
ity of current mass spectrometers is not great enough to
detect many components in the ultratrace amounts
present in a single cell. Consequently, the number of
proteins identifiable by current single cell methods is
limited. MALDI-TOF mass spectrometry has been shown
to be effective for peptide profiling directly from a single
cell [65– 67]. In this approach, a single cell is transferred
onto a MALDI plate and 2,5-dihydroxybenzoic acid
(DHB) matrix solution is used as a cell rinsing reagent in
addition to acting as theMALDImatrix. Both extracellular
and intracellular salts can be removed in a stepwise
fashion by spot-to-spot cell transfers to a freshmatrix drop
on the sample plate.
In this report, we present a simple and direct ap-
proach to obtain unique fingerprint information to
differentiate mammalian cell types using MALDI-MS.
The approach is rapid and works for a few cells
(1000), and as such is potentially well suited to
high-throughput analyses. Cells were placed in matrix
solution and analyzed by MALDI-MS directly after the
mixing of cell contents with the matrix solution. Three
different MALDI matrices (DHB, SA, and CHCA) were
used to directly extract and analyze mammalian cells
and the MALDI-TOF results are compared among these
matrices. Three different mammalian cell lines were
analyzed using DHB as the extraction matrix, and
found to produce unique and reproducible MALDI
fingerprints that can be utilized to identify these cell
lines. MALDI-PSD, MALDI TOF-TOF, and MALDI-
FTICR direct analyses of these samples showed limited
ability to produce useful sequence information. LC-ESI-
MS/MS analyses of a tryptic digestion of these samples
did provide useful sequence information, permitting
identification of a number of proteins from the different
cell lines.
Experimental
Reagents
The cell lines K562, BHK21, and GM15226 were all
obtained from ATCC (Manassas, VA). K562 and
GM15226 were cultured in 5% CO2 in a 37 °C incu-
bator with RPMI-1640 containing 1% glutamine, 1%
penicillin-streptomycin, and 15% fetal bovine serum
(FBS, Invitrogen, Carlsbad, CA) as culture medium.BHK21 was cultured in Dulbecco’s modified essential
medium/F-12 medium supplemented with 5% FBS
and penicillin-streptomycin (60 g/mL) and was
incubated in 5% CO2 in a 37 °C incubator.
DHB (2,5-dihydroxybenzoic acid), 4-hydroxy--
cyanocinnamic acid (4-CHCA), 3,5-dimethyl-4-hy-
droxycinnamic acid (sinapinic acid), and a Proteo-
Mass Peptide and Protein MALDI-MS Calibration Kit
were obtained from Sigma (St. Louis, MO). Sequenc-
ing-grade modified trypsin was from Promega (Mad-
ison, WI). HPLC-grade water was obtained from
Honeywell B&J (Muskegon, MI). HPLC-grade aceto-
nitrile and formic acid were obtained from Fischer
Scientific (Philadelphia, PA).
Sample Preparation
DHB extraction and rinsing of cells. Approximately 106
cells taken directly from cell culture were centrifuged at
1600 rpm for 5 min at 5 °C, and the supernatant was
discarded. The cell pellet was either resuspended di-
rectly in 100 l MALDI matrix solution (only in the case
of the “no rinse” comparison in Figure 5) or subse-
quently washed twice with 100 l 10 mg/mL DHB
solution before resuspension in the same solution (for
all other analyses). The washing process involved vor-
texing the samples for a few seconds, centrifuging the
samples, and discarding the supernatant. After the
second wash step, the cells were resuspended in DHB
solution and analyzed by MALDI mass spectrometry.
Tryptic Digestion for LC-ESI-MS/MS analysis. One mL
of the DHB extracted supernatant was dried in a
SpeedVac (Thermo Savant, Holbrook, NY) and a stan-
dard in-solution tryptic digestion procedure was per-
formed. Briefly, the sample was reconstituted in 200 l
8M urea, 0.4M NH4HCO3, reduced by adding 10 l 100
mM dithiothreitol in 50 mM NH4HCO3 and then alky-
lated by the addition of 20 l 100 mM iodoacetamide in
50 mM NH4HCO3. The urea concentration was diluted
to2 M by the addition of 770 l water, followed by the
addition of 40 l 0.25 g/l modified trypsin (Pro-
mega, Madison, WI). Tryptic digestion was carried out
overnight at 37 °C. The digested samples were purified
using C18 ziptips (Millipore, Bedford, MA) and then
resuspended in 10 l 50% ACN  0.1% formic acid
before LC-ESI-MS/MS analysis.
MALDI-TOF MS analysis. MALDI-TOF mass spectra
of DHB rinsed and resuspended cells were obtained
using a Voyager-DE STR mass spectrometer (Applied
Biosystems, Foster City, CA). One l of the DHB rinsed
and resuspended cells were spotted directly onto the
MALDI plate (Figures 1, 4, 5, 6) or mixed with 1 l
matrix (4-CHCA or sinapinic acid, Figure 3). A pulsed
nitrogen laser (337 nm) was used for desorption/
ionization and positive ion mass spectra were acquired
in linear mode. The total acceleration voltage was 25
kV, grid voltage at 92.7%, guide wire voltage at 0.25%,
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calibration was performed using insulin and angioten-
sin I. Spectra were obtained by accumulating data from
50 laser shots.
Photomicrographs of MALDI samples were obtained
using a Nikon Eclipse ME600 microscope (Melville,
NY).
MALDI-TOF/TOF. Samples of the DHB rinsed and
resuspended cells were sent to Bruker and Applied
Biosystem for MALDI-TOF/TOF analysis on a Bruker
UltraflexII or an ABI 4700, respectively. In each case, 1
l of DHB rinsed and resuspended cells were directly
spotted onto the MALDI plate for analysis, or alterna-
tively mixed 1:1 with -cyano-3-hydroxycinnamic acid
matrix (5 mg/mL in 50% ACN  0.1% TFA), followed
by spotting onto the MALDI plate.
Samples were analyzed in positive ion mode in both
reflector and MS/MS acquisition modes with a laser
repetition rate of 200 Hz. In MS/MS mode, 1 kV
collision energy (with CID gas ON) was used to frag-
ment the peptides. In both reflector and MSMS modes,
the instrument default calibration was used.
MALDI-FTICR analysis. The tryptic digest of the DHB
extracted supernatant was analyzed by MALDI-FTICR.
One l of sample was mixed 1:1 with DHB matrix and
spotted onto a MALDI plate. MALDI-FTICR experi-
ments were performed on an Ionspec Fourier transform
mass spectrometer (Lake Forest, CA) equipped with a
7.0-T actively shielded superconducting magnet. An
external 337 nm nitrogen laser (Laser Science, Inc.,
Franklin, MA) was used for ionization/desorption. A
quadrupole ion guide was used to transfer the ions to
the ICR cell, which was differentially pumped.
MALDI-PSD fragmentation analysis. The tryptic digest
of the DHB extracted supernatant was analyzed by
MALDI-PSD. One l of sample was mixed 1:1 with
DHB matrix and spotted onto a MALDI plate. PSD
spectra were obtained using a Voyager-DE STR mass
spectrometer (Applied Biosystems). By using a timed
ion selector, different precursor ions can be selected and
subjected to fragmentation. To obtain a complete PSD
spectrum, a series of reflectron TOF spectral segments
were acquired, each optimized to focus fragment ions
within different m/z ranges. A composite PSD spectrum
was generated using the Voyager 5.1 Dataexplore soft-
ware (Applied Biosystem).
LC-ESI-MS/MS analysis. The same tryptic digest of the
DHB extracted supernatant was also analyzed by LC-
ESI-MS/MS. The LC-ESI-MS/MS system consists of an
HPLC connected to an ESI ion trap mass spectrometer
(Surveyor HPLC and LCQ deca XPplus, Thermo Finni-
gan, San Jose, CA). A fritless 100  365 m fused-silica
capillary micro-column was prepared by pulling the tip
of the capillary to 2 m with a P-2000 laser puller
(Sutter Instruments Co., Novato, CA), and packing with10 cm of 5 m diameter, 300 Å pore size C18 beads
(Western Analytical Products, Inc., Murrieta, CA). The
capillary column was connected to the HPLC through a
polyetheretherketone (PEEK) microcross with a plati-
num wire inserted into the flow-through to supply a
spray voltage of 1.8 kV.
The lyophilized, zip-tip purified tryptic digest was
reconstituted in 10 l of 0.1% formic acid in water. After
injecting 10 l of sample onto the column, a 30 min
load/wash with 95% buffer A (0.1% vol/vol formic acid
in water) was applied at a flow-rate of 1 l /min.
Peptides were eluted using a linear gradient of 5%
buffer B (0.1% vol/vol formic acid in acetonitrile) to
80% buffer B over 160 min with a constant flow rate of
300 nL/min.
The ion trap mass spectrometer was operated in
“biggest 3” mode. Each full-mass scan was performed
between 400–2000 m/z, followed by three MS/MS scans
of the three highest intensity parent ions at 45% relative
collision energy. Dynamic exclusion was enabled with a
repeat count of 3, exclusion duration of 3 min, and
repeat duration of 1min.
The acquired MS/MS spectra were searched
against either a human (K562 and GM15226) or a
rodent (BHK21) protein database (created from the
non-redundant protein database available through
NCBI) using the SEQUEST program (Thermo Finni-
gan, San Jose, CA). Peptide matches were accepted if
they met the following criteria: (1) fully tryptic; (2)
Cn 0.1; (3) Xcorr scores 1.9 for 1 peptides, 2.2
for 2 peptides, and 3.75 for 3 peptides.
Results and Discussion
To optimize the direct MALDI-MS analyses of cells
suspended directly in matrix, K562 was selected as a
model cell line because of its robustness and relative
stability. K562 is a human myelo-monocytic cell line
that was derived from a chronic myelogenous leukemic
patient [68].
After centrifugation and removal of the cell growth
medium, the cell pellet was placed in a 10 mg/ml
2,5-dihydroxybenzoic acid (DHB) solution to allow
mixing of the cell contents with the matrix solution.
This mixture of cells and DHB matrix was analyzed
directly by MALDI-MS without further purification. It
was somewhat surprising that unique and reproducible
mass spectra were obtained without further sample
clean-up. The mass spectra of whole cell mixtures
generally exhibit a large number of discrete peaks in the
m/z range between 1000 and 20,000 Da. Three spectra of
K562 cell mixtures from independent cell cultures are
shown in Figure 1.
Replicate experiments were performed on three
successive generations and over 20 discontinuous
generations of K562 cells and the same peak pattern
as shown in Figure 1 was obtained each time. This
result indicates that despite expected variations in
some protein expression levels due to growth condi-
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cell line yields a distinct mass spectral signature.
The same cell mixture was also analyzed using
SDS-PAGE (data not shown). An intense band around
66 kDa corresponds to the molecular weight of fetal
bovine serum albumin (fBSA), which is a main compo-
nent in the culture medium. Several less intense bands
in the 30–60 kDa mass range were also observed. As
shown in the mass spectrum of this same cell mixture
(Figure 1), only ions of 22 kDa or lower m/z were
detected with high intensity. Although this sample was
analyzed using various settings of MALDI-MS instru-
mental parameters favoring the detection of larger
proteins, the only peak observed above 22 kDa was a
broad and low-intensity peak at 66 kDa corresponding
to fBSA (data not shown). Larger proteins are often not
detected by MALDI analysis because of a combination
of widely variable ionization efficiencies and the lower
detection efficiency of the instrument for higher mass
ions [69]. In this case, there is possibly ionization
suppression and/or a smaller population of desorbed
larger proteins due to the presence of so many smaller
proteins and peptides.
Although MALDI is relatively tolerant of impurities,
the ability to obtain quality mass spectra is highly
dependent on crystal formation, salt concentration, and
sample size. As observed during the course of these
experiments, only cells embedded in DHB matrix crys-
tals yielded highly intense signals. Figure 2 shows an
example of cells crystallized with DHB on a MALDI
sample plate observed under a microscope.
Effect of Different Matrix
Careful selection of the appropriate matrix is an impor-
tant issue for optimum MALDI analyses. 4-
hydroxy--cyanocinnamic acid (4-CHCA) and 3,5-di-
Figure 1. MALDI-TOF mass spectra of K562 cells in DHB matrix
from three independent cell cultures.methyl-4-hydroxycinnamic acid (SA) have both previ-ously been used as matrices for bacterial cell analyses
[3, 4, 7]. DHB has been the most commonly used matrix
for single-cell MALDI studies because it serves to aid in
microdissections by stabilizing cell membranes and also
best eliminates the salt effect [67, 70]. To determine the
optimum matrix for mammalian whole-cell analyses,
each of these three MALDI matrix solutions was ap-
plied to the centrifuged K562 cell pellet and the result-
ing MALDI spectra are shown in Figure 3. The best
overall results were obtained using pure DHB as ma-
trix, and accordingly it was employed for all the subse-
quent MALDI analyses.
Analysis of Supernatant and Effect of Rinsing
Steps
There is a possibility that some proteins are lost in the
supernatant if indeed the cells lyse in matrix solution.
Therefore, we analyzed the supernatant after the initial
suspension and subsequent centrifugation of the cells in
DHB solution. After cell culture medium removal, the
Figure 2. K562 cells co-crystallized with DHB matrix.
Figure 3. MALDI-TOF mass spectra of K562 cells extracted in
different matrices.
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trifuged again. The supernatant was reserved for
MALDI analysis, labeled supernatant 1 (Figure 4a).
After resuspending and centrifuging a second time in
DHB, the supernatant was again reserved for MALDI
analysis (Figure 4b, supernatant 2). Finally, the cells
were resuspended a third time in DHB and an aliquot
including cells was analyzed by MALDI-MS (Figure 4c,
cells). The MALDI spectrum of the supernatant from
the first DHB rinse (Figure 4a) shows a single, high
intensity peak at 4962 m/z. Figure 4b, corresponding to
the supernatant from the second DHB rinse, shows a
series of peaks throughout the mass range of 1000 to
15,000kDa, which are similar although less intense than
those from analysis of cells (Figure 4c). The similarity
between the peak pattern evident in Figure 4b and c
shows that likely the cells are being lysed in DHB
solution and cytoplasmic proteins are released into the
supernatant.
Interestingly, the peak at 4962 Da completely disap-
pears with the second DHB rinse step. This result shows
that a large amount of protein with m/z 4962 Da was
extracted into the matrix solution during the first DHB
rinse step. A previous study of human erythroleukemia
cells [41] identified a peak at m/z 4962 as thymosin  4,
a 43 amino acid polypeptide rich in glutamic acid and
lysine. Thymosin  4 was shown to be widely distrib-
uted in many tissues and is thought to be an important
mediator in cell proliferation, migration, and differen-
tiation.
Rinsing in DHB matrix has been shown to remove
salts from MALDI samples and also probably lyses the
cells [3, 4, 7] releasing intracellular proteins. For com-
parison, a portion of BHK21 cells were also MALDI
analyzed without any rinsing steps. The results are
Figure 4. Representative MALDI mass spectra of K562 cells
extracted and rinsed in DHB matrix. (a) Supernatant from the first
DHB rinse; (b) supernatant from the second DHB rinse; (c) K562
cells after two DHB rinses.shown in Figure 5, with both spectra plotted on the
same intensity scale. The main difference between the
spectra is the intensity of the peak at 4962 Da. Without
rinsing (Figure 5a), the 4962 Da peak is much more
intense than in the spectrum of cells rinsed in DHB
solution (Figure 5b). This result again shows that this
protein was extracted into the matrix solution during
the DHB rinsing step. Comparing Figure 5a and b
shows that the peaks at higher m/z possess both higher
intensity and better S/N when the DHB rinsing step is
included.
A series of peaks centered around 11 and 14 kDa do
not appear intensely in the spectra obtained from cells
without DHB rinsing. These two groups of peaks have
been determined by LC-ESI-MS/MS to correspond to
different forms of histones (see below). Histones are a
common protein in all eukaryotic cells and are respon-
sible for packaging and ordering the DNA into nucleo-
somes. After DHB matrix rinsing, the intensities of the
histone peaks increase significantly, probably because
the cells were lysed and the histones were released from
the nuclear membrane. Peaks at m/z 11,290, 11,323, and
11,432 Da are associated with multiply modified forms
of histone H4. The peak at 13,763 is identified as histone
H2B*. A grouping of three peaks at 13,993, 14,022, and
14,123 Da correspond to the different forms of histone
H2A*.
MALDI Analysis of Three Mammalian Cell Lines
Two additional mammalian cell lines, GM15226 and
BHK21, were analyzed following the optimized DHB
suspension and rinsing procedure presented above.
BHK21 is a fibroblast cell line derived from baby
hamster kidney [71], and GM15226 is a human lympho-
blast cell line. The results obtained from whole cell
MALDI-MS analysis of the three different cell lines are
shown in Figure 6. As shown in Figure 6, profiles of the
Figure 5. MALDI-TOF mass spectra of BHK21 cells. (a) No rinse;
(b) DHB matrix solution rinse (see Experimental section for
details). The inset is the full scale spectrum of (a).three different cell types are easily distinguished by
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observed for all three cell lines are common, there are
also a number of unique peaks distinguishing each cell
line. Both the peaks in common and the peaks specific
to a cell line observed during the MALDI-MS analysis
of these three cell lines are summarized in Table 1. The
specific peaks for each variety of cell can be utilized as
a “fingerprint” to identify that cell type.
Attempts to Identify Proteins—Peptide Mass
Fingerprint, PSD, TOF-TOF, MALDI-FTICR,
LC-ESI-MS/MS
MALDI-MS is a rapid and straightforward method to
generate peak patterns from whole cells. The analyses
of three different cell lines shown here produce unique
patterns, and it is desirable and important to identify
those peaks specific to each different cell line. This
problem of protein/peptide identification of a specific
peak in a complicated MALDI spectrum is a challenge
that is commonly faced by many researchers in the field
of biomarker analyses [20, 22–24]. Here, we explored
both bottom-up and top-down approaches to identify
Figure 6. MALDI-TOF mass spectra of three different mamma-
lian cell lines in DHB. The asterisk denotes peaks in each MALDI
spectrum that are unique to that cell line.
Table 1. Comparison of peaks in MALDI-MS analysis of three d
Cell type
Common markers among all three cell
lines (m/z)
K562 3005, 3156, 3457, 4963, 6273, 6879, 8552,
11290, 13762
GM15226 3005, 3156, 3458, 4962, 6275, 6880, 8553,
11289, 13763
BHK21 3004, 3154, 3456, 4962, 6273, 6879, 8552,
11292, 13760some of the proteins present in the DHB extractant of
whole cells.
A standard reduction and alkylation followed by
tryptic digestion was performed on the supernatant of
K562 cells in DHBmatrix solution (see the Experimental
section for details). The digested mixture was analyzed
by LC-ESI-MS/MS (see below) and by MALDI-MS for
peptide mass fingerprint identification of proteins (data
not shown). Several peaks identified as peptides origi-
nating from histones (1777, 1761, 1797, 1326, 1311, 1094)
and ribosomal proteins (1838, 1233, 942, 1087) in the
LC-ESI-MS/MS run of this same sample were also
evident in the MALDI-TOF spectra. However, due to
the extreme complexity of this sample, MALDI mass
fingerprinting was not attempted for identification of
the proteins.
The same digested mixture used for MALDI peptide
mass fingerprinting was also analyzed by MALDI-post
source decay (PSD). PSD is a fragmentation method
used in MALDI-MS analyses to obtain additional infor-
mation for identification. The ions fragmenting in the
field-free region of the drift tube (metastable decay) are
separated by their difference in kinetic energy using an
ion reflector. However, PSD is not very sensitive and
cannot handle very complex samples [66, 67]. In addi-
tion, PSD has an effective upper m/z limit of 2000 Da
because peptides larger than 2000 Da tend not to
fragment very well [66, 67]. We attempted PSD frag-
mentation of four different peaks below 2000 Da [1326,
1233, 1094, 942] present in the MALDI spectrum of K562
cells. We found that the signal intensity was too low
and not enough fragments could be generated for
confident identification.
MALDI-FTICR is well known for high sensitivity
and high-resolution. The same tryptically digested mix-
ture was analyzed by MALDI-FTICR. Three peptides
with the highest signal intensities (2212, 1795, 1695 m/z)
were subjected to fragmentation analysis in an attempt
to identify them. Stored waveform inverse Fourier
transform (SWIFT) technique [72–75] was employed for
mass-selective ion injection, accumulation, and isola-
tion, followed by sustained off resonance irradiation
and collision-induced dissociation (SORI-CID) [76 –78]
to fragment selected peptide ions. Nitrogen gas was
used to cool the ions and dissociate the peptides. The
SORI procedure (1000 ms in duration) employed a
frequency offset ranging from 1000 to 600 Hz and
ent mammalian cell types
mmon markers between
two cell lines (m/z) Unique cell markers (m/z)
4, 1525, 5730, 7873 1802, 1876, 1887, 2002,
5648, 6322, 6996
4, 1526, 5605, 5735, 10785 1675, 5443, 6665, 7813, 9109
1, 7872, 10775 1568, 2229, 3789, 6216,iffer
Co
126
126
560
6640, 9278, 10020, 10128
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the desired level of fragmentation and the energy
needed to dissociate the peptide. Because SORI-CID is a
relatively low-energy fragmentation process, it is gen-
erally most effective for peptides with molecular weight
below 2000 Da. As for the PSD experiments, too few
fragment ions were observed to allow confident identi-
fication of the three peptides. It should be noted that
newer fragmentation processes introduced over the last
several years, such as electron capture dissociation
(ECD) [79 – 82] and electron-transfer dissociation (ETD)
[83, 84], have significantly increased the ability of FT
instruments to obtain high-quality fragmentation re-
sults.
MALDI-TOF/TOF instruments are currently used
not only for the acquisition of peptide mass fingerprint
spectra, but also for subsequent protein identification
through CID fragmentation of selected precursor ions.
MALDI-TOF/TOF instruments have also recently been
Table 2. Proteins identified from DHB extraction of K562 cell b
Proteins identified
Histones
H2BL_HUMAN Histone H2B.1 (H2B/1) AM
H1 histone family, member 1 AL
H1 histone family, member 5 AL
Histone H4 homologue DN
IS
H1 histone family, member 3 SG
Histone H2A VG
Ribosomal proteins
Ribosomal protein L13 ST
Ribosomal protein L8 AV
Ribosomal protein L29 AQ
Ribosomal protein S19 DV
Ribosomal protein L26 KD
30S ribosomal protein S1 VK
Others
S34426 nuclease sensitive element-binding
protein 1
G
SV
Homo sapiens ATP synthase Q
aMARCKS-like protein (myristoylated alanine-
rich protein kinase C substrate)
G
aStathmin 1 AS
aCytokine induced protein 29kDa FG
Homo sapiens cytochrome C, somatic TG
RPS21 protein M
Hypothetical protein G
Nascent-polypeptide-associated complex alpha
polypeptide
IE
RICKEN cDNA 2210402A09 AE
Alpha NAC/1.9.2 protein N
Human thioredoxin mutant with Cys 73
replaced by Ser
TA
Chaperonin 10-related protein VL
Pheromone biosythesis activating neuropeptide TC
Cytokeratin 9 VQ
Keratin 1 FL
Keratin 10, type I, epidermal AL
aProteins specific to K562 leukemia cell or human cancer cellsemployed for top-down proteomic measurements, withone study reporting fragmentation of thioredoxin, an 11
kDa protein [85]. However, the upper m/z limit for
fragmentation is generally reported as between 4000–
5000 Da.
A sample of K562 cells extracted in DHB (see
Figure 1) was analyzed on two different MALDI-
TOF/TOF instruments (Bruker UltraflexII and ABI
4700). This sample represents a top-down approach
since the proteins have not been digested and are
presumably intact. Similar results were obtained with
both TOF-TOF instruments. A total of three peptides
were confidently identified by CID fragmentation in
both instruments. The identified peptides were
1366.74 Da (Histone H4-1), 1800.07 Da (Histone
H2A.1), and 1871.11 Da (Histone H2A.5). It is inter-
esting to note that no peptide above 2000 Da was
identified even though there are several high inten-
sity peaks around 3000 Da. Although instrument
manufacturer specifications claim that peptides in the
MS/MS
Peptide sequences
NSFVNDIFER, AM#GIMNSFVNDIFER, AMGIM#NSFVNDIFER
GYDVEK
GYDVEK
ITKPAIR
EETR
AALKK, KASGPPVSELITK
PVYLAAVLEYLTAEILELAGNAAR
QANVQR
VAGGGR
PASVPAQAPK
EFVR, AJLAAFLK
QVVR
DIISIGDEISVK
NVTGPGGVPVQGSK
ETVEFDVVEGEK
PVDASSEYQQELER
EEAAGASPAK
FELILSPR
SAGTGTTEDTEAK
GYSYTAANK
DSILR
WEAEAGGSR
QAQLAAAEK
GSATEFQFR
QQAQLAAAEK
ALDAAGDK
VVAVGSGSK
QLTRK
EANNDLENK
NQVLQTK, SLDLDSIIAEVK
NYELEGK, SLLEGEGSSGGGGRy LC/
GIM
AAA
AAG
IQG
GLIY
VSL
AGA
ESL
VGV
AAA
NQQ
NEV
HPS
AEAA
GDG
TSGG
DVTA
GQA
IVTS
QAP
GESD
GGCV
DLSQ
AGA
EDLS
FQE
QAT
LLR
ALE
EQQ
EES4000–5000 Da range may be utilized for CID fragmen-
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upper mass limit for unknown peptides in a complex
mixture remains around 2000 Da.
LC-ESI-MS/MS Analysis
The same digestion solution analyzed by MALDI-TOF,
MALDI-PSD, and MALDI-FTICR was separated and
analyzed using LC-ESI-MS/MS on an ion trap mass
spectrometer. Because the complicated peptide mixture
was separated over an LC column before MS/MS
analysis, significantly more peptides and proteins were
identified. The data were searched against a human
protein database using the Sequest database searching
program [86]. The combined database search results
from two separate LC-ESI-MS/MS runs of the same
digestion solution are shown in Table 2. Histones and
ribosomal proteins are the two main groups of proteins
identified. These results are consistent with those ob-
served in MALDI peptide mass fingerprint analysis of
the same sample, with several of the identified peptide
molecular weights matching peaks observed in the
MALDI spectra. Several different forms of histone ap-
pear to be highly abundant in the DHB extraction
solution. Several other proteins found in leukemia or
human tumor cells, such as MARCKS-like protein,
Stathmin 1, and Cytokine-induced protein were also
identified.
Conclusions
A simple, direct, rapid, and accurate mass spectrometric
method has been developed for identification of differ-
ent cell types. Cellular proteins were released by DHB
extraction of intact cells and analyzed by MALDI mass
spectrometry. The entire analytical process could be
completed within 10 min. Three different types of
mammalian cells were investigated and found to yield
unique and reproducible MALDI-MS patterns, which
can be used as a fingerprint to identify and distinguish
these different cell-lines. Attempts to identify these
unique biomarker peaks using several different MALDI
top-down technologies (TOF-TOF, PSD, FTICR) were
largely unsuccessful. Using the bottom-up proteomics
approach of LC-ESI-MS/MS analysis of a tryptic diges-
tion of the DHB extracted proteins, many proteins were
identified. Future developments in direct MALDI top-
down technology should allow for direct identification
of these biomarker peaks without prior separation. This
potentially powerful approach is well suited for auto-
mation and high throughput due to its simplicity.
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